» Articles » PMID: 25486569

Genetic Characterization of P27(kip1) and Stathmin in Controlling Cell Proliferation in Vivo

Abstract

The CDK inhibitor p27(kip1) is a critical regulator of cell cycle progression, but the mechanisms by which p27(kip1) controls cell proliferation in vivo are still not fully elucidated. We recently demonstrated that the microtubule destabilizing protein stathmin is a relevant p27(kip1) binding partner. To get more insights into the in vivo significance of this interaction, we generated p27(kip1) and stathmin double knock-out (DKO) mice. Interestingly, thorough characterization of DKO mice demonstrated that most of the phenotypes of p27(kip1) null mice linked to the hyper-proliferative behavior, such as the increased body and organ weight, the outgrowth of the retina basal layer and the development of pituitary adenomas, were reverted by co-ablation of stathmin. In vivo analyses showed a reduced proliferation rate in DKO compared to p27(kip1) null mice, linked, at molecular level, to decreased kinase activity of CDK4/6, rather than of CDK1 and CDK2. Gene expression profiling of mouse thymuses confirmed the phenotypes observed in vivo, showing that DKO clustered with WT more than with p27 knock-out tissue. Taken together, our results demonstrate that stathmin cooperates with p27(kip1) to control the early phase of G1 to S phase transition and that this function may be of particular relevance in the context of tumor progression.

Citing Articles

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Segatto I, Rampioni Vinciguerra G, Pellarin I, DallAcqua A, Berton S, Citron F Cancer Commun (Lond). 2023; 43(7):844-849.

PMID: 37337406 PMC: 10354406. DOI: 10.1002/cac2.12444.


HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.

Sgubin M, Pegoraro S, Pellarin I, Ros G, Sgarra R, Piazza S Cell Death Dis. 2022; 13(5):429.

PMID: 35504904 PMC: 9065117. DOI: 10.1038/s41419-022-04843-4.


p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.

Rampioni Vinciguerra G, DallAcqua A, Segatto I, Mattevi M, Russo F, Favero A Cell Death Dis. 2021; 12(10):951.

PMID: 34654798 PMC: 8519959. DOI: 10.1038/s41419-021-04241-2.


CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

Viotto D, Russo F, Anania I, Segatto I, Rampioni Vinciguerra G, DallAcqua A J Pathol. 2020; 253(2):234-245.

PMID: 33140857 PMC: 7839435. DOI: 10.1002/path.5584.


A non-canonical role for p27Kip1 in restricting proliferation of corneal endothelial cells during development.

Defoe D, Rao H, Harris 3rd D, Moore P, Brocher J, Harrison T PLoS One. 2020; 15(1):e0226725.

PMID: 31929545 PMC: 6957298. DOI: 10.1371/journal.pone.0226725.


References
1.
Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F . p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol. 2010; 30(9):2229-40. PMC: 2863592. DOI: 10.1128/MCB.00723-09. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Schiappacassi M, Lovisa S, Lovat F, Fabris L, Colombatti A, Belletti B . Role of T198 modification in the regulation of p27(Kip1) protein stability and function. PLoS One. 2011; 6(3):e17673. PMC: 3056717. DOI: 10.1371/journal.pone.0017673. View

4.
Good M, Zalatan J, Lim W . Scaffold proteins: hubs for controlling the flow of cellular information. Science. 2011; 332(6030):680-6. PMC: 3117218. DOI: 10.1126/science.1198701. View

5.
Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M . Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Mol Cell. 2011; 42(4):524-35. PMC: 3100487. DOI: 10.1016/j.molcel.2011.04.017. View